Serbia - Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics
Since 2014, Serbia Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics increased 2.4% year on year. In 2019, the country was ranked number 21 comparing other countries in Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics with €229,537,315.89. Serbia is overtaken by Bulgaria, which was number 20 at €340,961,504.22 and is followed by Lithuania at €119,740,673.33. Germany lead the ranking with €16,376,860,638.2 in 2019, that is +0.5% compared to 2018. Ireland, France and United Kingdom respectively ranked number 2, 3 and 4 in this ranking. Sweden recorded the best 5 years average growth at +62.7% per year, while Montenegro recorded the worst performance at -6.3% per year.
Loading...
| Date | Euros |
|---|---|
| 2019 | 229,537,315.89 |
| 2018 | 217,924,361.00 |
| 2017 | 201,259,057.00 |
| 2016 | 195,637,760.00 |
| 2015 | 210,666,851.00 |
How does Serbia rank in Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics?
| # | 29 Countries | Euros | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Germany
|
16,376,860,638.20 | 2019 | +0.5 % | +3.5 % | View data | |
| 2 |
#2
Ireland
|
14,139,386,320.45 | 2019 | +21.9 % | -5.8 % | View data | |
| 20 |
#20
Bulgaria
|
340,961,504.22 | 2019 | +2.3 % | +3.6 % | View data | |
| 21 |
#21
Serbia
|
229,537,315.89 | 2019 | +5.3 % | +2.4 % | View data | |
| 22 |
#22
Lithuania
|
119,740,673.33 | 2019 | +16.2 % | -1.6 % | View data | |